Home : DrugWatch : Sensipar : News Articles

Sensipar - News Articles

APOTHEKE ADHOC -- Neue Warnhinweise für Tamoxifen: Zu den Enzyminhibitoren zählen die Wirkstoffe Paroxetin, Fluoxetin, Bupropion, Chinidin und Cinacalcet. Außerdem können Patienten mit einem Polymorphismus des CYP2D6 anders auf das Brustkrebspräparat ansprechen; bei langsamen Metabolisierern (Poor-metabolizer) kann die Wirksamkeit eingeschränkt sein. Solche Patienten hätten ...
Court: Teva, Barr Labs must hold off on generic versions of Sensipar | Drug Store News: Amgen announced that a US District Court in Delaware ruled that the two companies would have to hold off launch of their version of Sensipar (cinacalcet) until 2018, when the last patent expires. The drug is used to treat secondary hyperparathyroidism in patients with CKD ...
Amgen overweight (Barclays Capital) | Analyse | finanzen.net: Amgen habe heute Daten aus einer Observationsstudie zum Medikament "Sensipar" veröffentlicht. Observationsstudien hätten zwar im Allgemeinen nur eine begrenzte Aussagekraft, angesichts der hohen Anzahl an Patienten, die an der Studie teilgenommen hätten, würden die jüngsten Daten jedoch ...
Vivir Mejor -Los nuevos f?rmacos frenan la progresi?n del hiperparatiroidismo secundario: Con cinco años de experiencia de cinacalcet, “sabemos usar mejor los calcimiméticos” afirmaba el Dr. Jorge Cannata, jefe del servicio de metabolismo óseo y ...

Salud, Medicina y Paciente - Medicina 21: Con cinco años de experiencia del calcimimético cinacalcet, el Dr. Jorge Cannata, jefe del servicio de metabolismo óseo y mineral del Hospital Central de Asturias de Oviedo, considera que ?sabemos usar mejor los calcimim?ticos?, al tiempo que asegura que ?el tratamiento del hiperparatiroidismo ...
Rhythm and Blues: The Case for Allosteric Modulators - Bio-IT World: But a handful of marketed molecules—Amgen's hyperparathyroidism drug cinacalcet and Pfizer's HIV inhibitor maraviroc are two examples—show the potential of a new class of drugs: allosteric modulators. By targeting other regions of a receptor ...
SHPT Treatment May Have CAC Benefit - Renal and Urology News: Cinacalcet plus low-dose vitamin D therapy may attenuate progression of coronary artery calcification (CAC) compared with flexible vitamin D therapy alone in hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT), according to a new study. It is well documented that ...

Want to contact a Sensipar lawyer in Washington, DC? ...Get a free case evaluation from one of our Sensipar lawyers in Washington, DC now.

Need A Sensipar Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Sensipar Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Sensipar Information

Click to View Our Legal Resources

Want to contact a Sensipar lawyer in Washington, DC? ...Get a free case evaluation from one of our Sensipar lawyers in Washington, DC now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-084237

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Sensipar Click to select a Legal Issue

Close (x)

Find Legal Help for Your Sensipar Case - Submit Your Information Below

Do you need legal assistance with your Sensipar case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Sensipar Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.